Understanding GOT2: The Potential Drug Target Or Biomarker (G645538)

Understanding GOT2: The Potential Drug Target Or Biomarker

GOT2P1, also known as GOT2 pseudogene 1, is a gene that encodes for a protein known as GOT2. GOT2 is a hereditary transthyretin gene that is expressed in various tissues throughout the body, including the liver, heart, kidneys, and muscles. It plays a crucial role in the metabolism of thyroxine (T4), which is a thyroid hormone that is responsible for regulating the body's metabolism and growth.

Mutations in the GOT2 gene have been linked to a range of genetic disorders, including hypothyroidism, hyperthyroidism, and myopathies. In addition, research has also shown that mutations in GOT2 can be associated with an increased risk of cardiovascular disease.

Despite the importance of GOT2 in the body, little is known about the protein itself. GOT2 has been shown to interact with several intracellular signaling pathways, including the TGF-β pathway and the PI3K/Akt pathway. It has also been shown to play a role in regulating cellular processes such as cell adhesion, migration, and apoptosis.

Despite the potential implications for GOT2 as a drug target or biomarker, much research is still needed to fully understand its role in the body. One promising avenue for research is the use of small molecules to modulate GOT2 activity. For example, recent studies have shown that inhibitors of the TGF-β pathway, which is activated by GOT2, can be effective in reducing the activity of GOT2 and protecting against its negative effects on various tissues.

Another approach to studying GOT2 is through the use of genetic modifiers, such as CRISPR/Cas9 genome editing technology. By using this technology, researchers have been able to make changes to the GOT2 gene that are then expressed as proteins and used to study its function. This approach has allowed researchers to gain a better understanding of the molecular mechanisms underlying GOT2 and its role in various physiological processes.

In addition to its potential as a drug target or biomarker, GOT2 also has implications for our understanding of the genetic basis of human disease. Studies have shown that mutations in GOT2 are often associated with a range of disorders, including hypothyroidism, hyperthyroidism, and myopathies. These mutations can occur at different levels of the gene, from missense mutations that result in the production of a functional but potentially harmful protein, to splicing variants that alter the structure and function of the protein.

Overall, GOT2P1 is an important gene that has implications for our understanding of the metabolism and regulation of thyroid hormones, as well as the development of various genetic disorders. Further research is needed to fully understand the role of GOT2 in the body and its potential as a drug target or biomarker.

Protein Name: GOT2 Pseudogene 1

The "GOT2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOT2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GP1BA | GP1BB | GP2 | GP5 | GP6 | GP9 | GPA33 | GPAA1 | GPALPP1 | GPAM | GPANK1 | GPAT2 | GPAT3 | GPAT4 | GPATCH1 | GPATCH11 | GPATCH2 | GPATCH2L | GPATCH3 | GPATCH4 | GPATCH8 | GPBAR1 | GPBP1 | GPBP1L1 | GPC1 | GPC1-AS1 | GPC2 | GPC3 | GPC4 | GPC5 | GPC5-AS1 | GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21